NEW YORK (TheStreet) -- Shares of CVS Caremark (CVS) are moving higher, after beating fourth-quarter earnings estimates. TheStreet's Brittany Umar takes a deeper look at the results. 

The company grew fourth-quarter earnings 12% year over year. Revenue grew 4.6% to $32.83 billion, Umar said. 

General merchandise sales sank 2% on lower store traffic, but CVS saw a big boost in pharmaceutical sales, which were up 7% as subscription fills climbed 3.8%, Umar added.  

Some investors have become worried about the company's future prospects after it announced that it would stop selling tobacco products by October of this year. 

However, the company reaffirmed 2014 guidance, easing investors' worries for now. Shares were up nearly 3% Tuesday trading.

-- Written by Bret Kenwell in Petoskey, Mich.

Bret Kenwell currently writes, blogs and also contributes to Robert Weinstein's Weekly Options Newsletter. Focuses on short-to-intermediate-term trading opportunities that can be exposed via options. He prefers to use debit trades on momentum setups and credit trades on support/resistance setups. He also focuses on building long-term wealth by searching for consistent, quality dividend paying companies and long-term growth companies. He considers himself the surfer, not the wave, in relation to the market and himself. He has no allegiance to either the bull side or the bear side.

More from Opinion

These 5 Tech Giants Still Aren't That Expensive

These 5 Tech Giants Still Aren't That Expensive

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

50 Stocks That Could Be Shredded If a U.S. Trade War With China Ignites

Intel CEO Brian Krzanich's Ouster Proves CEOs Aren't Above the Rules

Intel CEO Brian Krzanich's Ouster Proves CEOs Aren't Above the Rules

Red Hat CFO Tells TheStreet: Tech Trends Are Still in Our Favor

Red Hat CFO Tells TheStreet: Tech Trends Are Still in Our Favor

Throwback Thursday: Intel Edition

Throwback Thursday: Intel Edition